Načítá se...
RUNX3 is oncogenic in natural killer/T-cell lymphoma and is transcriptionally regulated by MYC
RUNX3, runt-domain transcription factor, is a master regulator of gene expression in major developmental pathways. It acts as a tumor suppressor in many cancers but is oncogenic in certain tumors. We observed upregulation of RUNX3 mRNA and protein expression in nasal-type extranodal natural killer (...
Uloženo v:
Vydáno v: | Leukemia |
---|---|
Hlavní autoři: | , , , , , , , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Nature Publishing Group
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5629367/ https://ncbi.nlm.nih.gov/pubmed/28119527 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/leu.2017.40 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|